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Abstract
Objectives: There is evidence about a possible relationship existing between periodontal diseases and coronary heart 
disease. The aim of the present longitudinal study was to investigate the changes in periodontal evolution after etio-
logical periodontal treatment, comparing a healthy control group with another having coronary heart disease. 
Study Design: The study included initially 55 patients of which 44 finished it. They were placed into two groups: 
Healthy Control Group (HCG) n =9, and Coronary Heart Disease Group (CHDG) n=35. The gingival level (GL), 
probing depth (PD), clinical attachment level (CAL), plaque index (PI) and bleeding on probing (BOP) were meas-
ured to compare the periodontal status in both groups. The patients were examined and etiological periodontal 
treatment was performed and they were then examined at the end of 1 and 10 years. Statistical method: A one 
way-ANOVA and a MR-ANOVA were established; significance p<0.05. 
Results: No significant differences between both groups were detected on the first visit (p>0.5). However, at the 
second visit the CHDG presented a significantly higher PD (p<0.05) and PI (p<0.01). CHDG patients gradually 
increase PD through time and in comparison to the control group (p<0.041). CHDG patients present a significantly 
higher CAL loss (p<0.0385) and a significant increase in PI (p<0.0041) at the end of one year, while on the third 
visit no significant differences were detected in any of these indices. Likewise, a similar fact can be observed on 
evaluating BOP at the end of ten years causal treatment, a smaller decrease in the cardiac group was observed in 
regards to the initial values (p<0.001).
Conclusion: Patients with coronary heart disease showed a worse evolution of periodontal indices than healthy 
ones, when referring to probing depth, plaque index and bleeding on probing index. 
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Introduction
Coronary heart diseases (CHD) suppose a major health 
problem in today’s society in industrialized countries 
and they are the main cause of mortality in both men 
and women (1). 
Ischemic cardiopathy has a multifactorial origin. The 
factors which predispose it must fulfil causality crite-
rion: strength of association (relative high risk), consist-
ency of association (demonstrated in several studies), 
temporal relationship (cause precedes effect), biological 
acceptability, experimental proof and above all, evi-
dence of studies in humans. From this point of view, 
the importance that periodontal diseases could have as 
a risk factor in CHD has been debated (2-4). However, 
a uniformity of criterion about the impact that perio-
dontal pathology could have on cardiovascular diseases 
still does not exist. As opposed to the relatively recent 
cohorts studies, carried out on a great number of pa-
tients that associate periodontal disease and death due 
to cardiovascular diseases (5), or periodontal disease 
and a high risk of suffering cerebrovascular events (6), 
there are other equally important and numerous cohorts 
studies with contrasting results (7-9). The fact must be 
considered that case-control designed studies, that try 
to clarify this aspect as well, also present contrasting 
results. Therefore, greater dental indexes have been 
found in acute myocardial infarction cases than in the 
control group (10), while in another similar study on 
an elderly population, the results did not confirm pre-
vious findings (11). Nevertheless, a series of scientific 
evidence exists which would postulate in favor of said 
association. Amongst these, the relationship found be-
tween periodontitis and atheromatosis is highlighted, in 
such a way that an increase of the intima of vessels and 
a higher index of atheromatosis has been described in 
patients with active periodontitis than in those who do 
not suffer it (12). In the same way the appearance of 
periodontal pathogens in cultives of atheromas obtained 
from endarterectomies by carotid pathology are high-
lighted (13). Thus Offenbacher et al. have gone so far 
as to postulate a PAS syndrome (“periodontitis-athero-
sclerosis syndrome”) which unites both concepts (5). In 
this sense it would really be important to clarify this 
concept from the point of view of public health, since 
to really establish an unmistakable relationship would 
imply an adequate and precocious foundation of peri-
odontal treatment, reducing the risk of cardiovascular 
disease in these patients (14).
It is difficult to find long term longitudinal studies in this 
type of populations, as the difficulty of their planning, 
and above all the loss of individuals in the study over an 
extensive period of time can lead to their failure, espe-
cially, when bearing in mind these patients’ precarious 
health. However, when these studies are instituted, they 
can give quite an enlightening idea about the implica-
tions that periodontal disease can have on cardiovascu-
lar diseases and vice versa (15). In this way, the present 
study has been established in which the changes in re-
sponse to periodontal treatment when a cardiologically 
healthy control group and another which had undergone 
coronary diseases are compared.
Material and Methods
Sample selection
Healthy control group (HCG)
Twelve patients were classified in this group, although 
only 9 finished the study at 10 years, fulfilling all the 
requisites. The patients in this group were chosen at 
random among the ones who applied for a first visit to 
Department of Periodontology, Dental School, Univer-
sity of Seville for 6 months. All of them had at least 
two pockets, with probing depths between 3 and 5.5 
mm. None of them had previously consumed calcium 
antagonists, beta-blockers or other medication related 
to cardiological or immunosuppressor diseases. So as to 
avoid the presence of non-diagnosed cardiac diseases, 
all of them were examined at the Cardiology Service at 
the University Hospital Virgen Macarena of Seville to 
verify the non-existence of cardiovascular disease. The 
study consisted of blood and urine analysis, measure-
ment of arterial pressure, electrocardiogram, ausculta-
tion and posteroanterior radiography of the chest. None 
of these patients developed any cardiological diseases 
during the ten years.
Coronary heart diseases group (CHDG)
Forty three patients were classified in this group, al-
though only 35 were taken into consideration for the 10 
year study, fulfilling all the requisites. Over a 6-month 
period a group of patients treated at the same Depart-
ment of Cardiology were asked to take part in the study. 
All of them had the following common characteristics: 
(a) they were suffering from some degree of ischem-
ic heart disease; (b) they did not suffer any other rel-
evant systemic pathology; (c) their treatment was based 
on the use of calcium channel blockers (nifedipine or 
diltiazem), beta-blockers and coumarin anticoagulants. 
In summary, of the 55 patients of both sexes that started 
the study only 44 finished it, thus the subsequent study 
refers to these 44 patients. Special precautions were tak-
en so that the patients’ general health was not affected 
by the study. After informing the patients, each signed 
an informed consent form. The Ethics and Investiga-
tion Committee of the hospital authorized the protocol. 
Clinical and periodontal examination
Gingival level, clinical attachment level and probing 
depth
All the participants were examined by the same exam-
iner using a controlled pressure probe (VINE VALLEY 
RESEARCH MODEL 205, 1037 South Lake Road. Mid-
dlesex New York 14507), with which a probing pressure 
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of 177 N/cm could be obtained. The number of teeth 
present was collected excluding the third molars. Six 
measures were taken for each tooth, three in vestibular 
(distal, vestibular, mesial) and another three in palati-
num/lingual. Thus three readings were obtained at each 
site: 1) Gingival level (GL): from the cementum-enamel 
junction to the gingival margin. 2) Clinical attachment 
level (CAL): from the cementum-enamel junction line 
to the most apical area where the probe penetrates. 3) 
Probing depth (PD): from the free gingival margin to 
the most apical area of probe penetration. 
Plaque index and bleeding on probing
The presence or absence of plaque was collected follow-
ing the O’Leary et al. (16) plaque index (PI), recorded 
on the four faces of the tooth. Plaque absence was re-
corded as zero (0), and presence as one (1). 
The bleeding on probing (BOP) index registers absence 
of (absence=0) or presence of (presence=1) bleeding at 
the moment of probing, following the index suggested 
by Van der Velden (17), with the same electronic con-
trolled pressure probe.
All these measurements were recorded at the beginning 
of the study, at twelve months and at ten years by the 
same examiner, at double blind, that had previously been 
calibrated to assure the reproducibility of the study.
On the first visit all the patients were instructed to use 
the Bass sulcular brushing technique, and interdental 
brushing using interproximal toothbrushes for oral hy-
giene. Likewise, root planning and a dental polishing 
under local anaesthetic were performed, in four ses-
sions, using universal periodontal curets (Columbia 
13-14 and 4R-4L). At one year, patients were reviewed 
again and all the aforementioned measures recorded. 
The same procedures were carried out at ten years. 
During the latency period between the last two exami-
nations, patients were recommended to visit their own 
dentist regularly.
Statistical Analysis
Descriptive statistics of the measurements (Mean and 
Standard Deviation) were used, calculated for each var-
iable on each visit. The adjustment of comparison be-
tween groups was carried out between the basal meas-
urement (1st) and the data from the second and third 
visit (at one and ten years). When statistically signifi-
cant differences were established, the Newman-Keuls 
Student Multiparametric Test was applied. PI and BOP 
values were expressed referring to the sites of the arch 
that showed plaques or bleeding in each individual. A 
one-way analysis of variance test (ANOVA) was used 
regarding cutting variables. To analyze the changes be-
tween visits and the valuation of the different variables 
(gingival level, pocket, loss of attachment, plaque and 
bleeding), a repeated measuring analysis of variance 
(RM-ANOVA) was utilized, considering the normal-
ity of variables. To detect whether the consumption of 
calcium antagonist drugs was interfering in periodontal 
indices a two-way analysis of variance (ANOVA) was 
used. However, when any type of significant interac-
tion was detected amongst the different factors (study 
group or visit), the Wilcoxon multiple comparison test 
was used, adjusting the signification levels by means of 
Bonferroni criteria. The established signification level 
was p<0.05.
Results
Table 1 shows the periodontal status indicators in the 
HCG and the CHDG at the 1st visit and at the end of the 
year (2nd visit). No significant differences between both 
groups were detected on the first visit (p>0.5). However, 
at the second visit the CHDG presented a significantly 
higher PD (p<0.05) and PI (p<0.01). On carrying out a 
comparison between both groups and visits conjunctly 
(MR-ANOVA) significant differences are found, so that 
Index Initial p One year p p total 
 All HCG CHDG  All HCG CHDG   
GL -1,1 ±1,4 -0,6 ± 0,7 -1,2 ± 1,6 * -0,9 ± 1,8 -0,5 ± 0,9 -1,0 ± 2,0 * * 
PD 3,5 ± 1,1 3,4 ± 1,2 3,6 ± 12 * 4,0 ± 1,6 3,0 ± 1,3 4,2 ± 1,5 ** ** 
CAL 4,6 ± 1,6 4,0 ± 1,8 4,8 ± 1,6 * 4,9 ± 2,5 3,5 ± 1,6 5,2 ± 2,6 * * 
PI 86,8 ± 15,3 81,9 ± 13,0 88,1 ± 15,8 * 65,9 ± 24,3 46,5 ± 25,8 70,9 ± 21,6 *** ** # 
BOP 46,7 ± 20,5 50,1 ± 16,3 45,9 ± 21,6 * 27,6 ± 16,0 23,1 ± 13,1 28,8 ± 16,6 * *** † 
Table 1. Periodontal status indicators in the healthy control group (HCG) and the coronary heart diseases group (CHDG) referred to the 
initial and one year visits (n=44).
GL: gingival level. PD: probing depth. CAL: clinical attachment loss.
PI: plaque index. BOP: bleeding on probing. 
* p > 0.05; ** p < 0.05; ***p < 0.001.
# Differences between groups and visits.
† Differences between visit.
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the coronary cardiopathy group patients gradually in-
crease PD through time and in comparison to the con-
trol group (p<0.041). Likewise, a similar fact can be 
seen on evaluating PI at the end of one year’s causal 
treatment, a small decrease in the cardiac group being 
observed in respect to the initial values, as opposed to 
the healthy control group (p<0.043). On the other hand, 
significant differences were detected in the evolution 
between visits, which was not so when evaluating BOP 
between groups, so a significant reduction (p<0.007) 
can be seen at the end of a year’s treatment. 
Table 2 shows the relationship between the indicators 
Index  Initial  p  One year  p  Ten years  p pTotal
 All Healthy Group 
Cardiac 
Group  All 
Healthy 
Group 
Cardiac 
Group  All 
Healthy 
Group 
Cardiac 
Group 
GL -0,9 ± 3,5 -0,6 ± 0,7 -0,9 ± 1,3 * -1,1 ± 3,9 -0,5 ± 0,9 -1,3 ± 1,2 * -1,4 ± 4,2 -1,0 ± 0,9 -1,6 ± 1,3 * * 
PD 3,9 ± 2,1 3,4 ± 1,2 3,8 ± 1,1 * 3,8 ± 1,7 3,0 ± 1,3 4,1 ± 1,5 * 3,4 ± 1,8 2,7 ± 1,0 3,6 ± 1,4 * * 
CAL 4,5 ± 2,2 4,0 ± 1,8 4,7 ± 1,5 * 5,0 ± 1,7 3,5 ± 1,6 5,4 ± 2,5 ** 4,8 ± 1,8 3,7 ± 1,6 5,2 ± 2,4 * * 
PI 87,1 ±  35,8 81,9 ± 13,0  88,8 ± 14,7 * 66,1 ± 3,3 46,5 ± 25,8 72,6 ± 20,7 *** 75,5 ± 21,1 65,5 ± 20,9 79,6 ± 24,6 * ** # 
BOP 45,7 ± 16,7 50,1 ± 16,4 44,3 ± 17,5 * 27,6 ± 8,7 23,1 ± 13,1  29,1 ± 16,0 * 38,1 ± 0,0 33,4 ± 18,9 40.0 ± 24,7 * ** † 
Table 2. Comparison between healthy control group (HCG) and the coronary heart diseases group (CHDG) referred to  first  (initial), second 
(1 year) and third (10 year) visit.
8 individuals who died are not registered (n=36).
GL: gingival level. PD: probing depth. CAL: clinical attachment loss.
PI: plaque index. BOP: bleeding on probing. 
* p > 0.05; ** p < 0.05; ***p < 0.001.
# Differences between groups and visits.
† Differences between visit.
of the periodontal status and the coronary cardiopa-
thy patients and control group on the initial (1st visit), 
at the end of one year (2nd visit) and at ten years (3rd 
visit). To evaluate these parameters only patients that 
were still alive at the end of ten years have been con-
sidered. Whereas no significant differences are found 
when comparing both groups on the control visit, it can 
be seen how the cardiac patients present a significantly 
higher CAL loss (p<0.0385) and a significant increase 
in PI (p<0.0041) at the end of one year, while on the 
third visit no significant differences were detected in 
any of these indices. Significant differences were found 
when comparing both groups and visits conjunctly 
(MR-ANOVA), in that the patients in the coronary car-
diopathy group gradually increased PI through time and 
in comparison to the control group (p<0.023). Likewise, 
a similar fact can be observed on evaluating BOP at the 
end of ten years causal treatment, a smaller decrease in 
the cardiac group was observed in regards to the initial 
values (p<0.001).
Discussion
The results of the present study corroborate those es-
tablished by previous studies (15,18,19), inasmuch that 
periodontal diseases and coronary diseases have, at 
least, a tendency to appear together, in such a way that 
individuals with cardiovascular problems have a greater 
tendency to have a worse periodontal status and vice 
versa, as happens in the present study. To what point it 
is an unequivocal relation remains to be clarified, and 
for this reason all papers would be justified, as in the 
present paper, in trying to throw some light on such a 
transcendental problem of community health.
Over the last few years numerous studies of different 
designs have been developed (case-control, prospective 
observational, retrospective observational, metanaly-
sis), which have produced contradictory results when 
evaluating the association between both diseases (7-18). 
According to Seymour et al. (19) studies to evaluate the 
relationship between periodontal and coronary diseases 
should have a series of characteristics, among which the 
specific choice of sample to study periodontal problems 
in cardiological patients, and not the reuse of previous 
studies for other ends, the use of specific periodontal 
indices, the fact that the examiners are calibrated and 
trained and a very careful management of covariables 
could be underlined. The present study is one of the 
first longitudinal studies carried out on this problem, 
which due to its characteristics reflects some of those 
expressed by Seymour et al. (19). However, the follow-
up of such a peculiar group of patients such as these 
over ten years contemplates a series of difficulties. 
Amongst these the loss of patients during the period 
of time (due to deaths, impossibility of locating them, 
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not fulfilling the later visits...) is outstanding. Another 
problem would be the difficulty of not being able to start 
with such a large sample as in the cohort studies, as a 
series of explorations and therapeutic procedures have 
to be performed on such a large number of patients that 
the study would be interminable. Yet, despite the results 
always having to be considered on the basis of particu-
lar restrictions of the study, the data they provide can 
contribute to throw some light on this important prob-
lem. This is due to working with a specifically chosen 
sample, with specific indices for the present periodontal 
study, taken directly, without being extrapolated from 
other samples for different purposes, with a unique cali-
brated and well-trained examiner (to reduce alfa error) 
and with a certain control over the covariables (medica-
tion consumption).
It is interesting to stress some aspects of the study. In the 
first place, with respect to the choice of sample, it has 
to be underlined that the patients in the healthy control 
group were chosen amongst patients who consulted be-
cause of suffering some type of periodontal problem, 
whereas the patients in the cardiological group were se-
lected on the basis of having a cardiac disease, and yet 
this group has periodontal characteristics comparable to 
the control group. Thus, while the patients in the control 
group did not show any cardiac affectation, all the pa-
tients in the cardiac group had some kind of periodontal 
affectation. On the other hand, it is interesting to stress 
that no significant differences existed in the periodontal 
situation of individuals with or without cardiopathies at 
the beginning of the study. The differences began to be 
seen when evaluating the response to etiological perio-
dontal treatment at the end of one year, when individuals 
with coronary cardiopathies not only reduced their PD at 
the end of a year but said index was increased. Likewise, 
PI and BOP indices were reduced after treatment at a 
lesser proportion in the cardiac group than in the control 
group, with a worse response to treatment in cardiopathy 
patients. This is an important fact, as it would indicate 
that the cardiopaths increased probing depth in the course 
of time, with a greater tendency to bleeding on probing, 
which would indicate the presence of a higher periodontal 
destructive activity. However, it should always be taken 
into account that these patients consume platelet antiag-
gregants that can sometimes alter the results of this index 
(20,21). It should also be considered that amongst all the 
evolutions of coronary pathology studied, patients whose 
illness would lead to death were the ones who showed a 
significantly worse evolution of probing depth (from 2.96 
to 4.58mm, while the control group improved from 3.37 
to 2.97mm, the deterioration in the myocardial infarction 
group was less, from 3.76 to 3.95mm). In fact, when these 
patients disappeared from the study (Table 2), only PI and 
BOP showed differences in respect to the healthy control 
group.
As calcium channel blockers can alter periodontal in-
flammatory response in different aspects is a demon-
strated fact (22,23), the interference that consumption 
of these drugs of such frequent use in ischemic cardio-
myopathy could have in the results of the present study 
was analyzed. It could be verified that said drugs did not 
significantly alter the results, so it must be assumed that 
alterations in the periodontal status shown would not be 
directly related to the consumption of these drugs. 
A high number of studies demonstrate a relationship 
between the accumulation of bacterial plaque and 
coronary disease, and above all between the gingival 
bleeding due to periodontal inflammation and the car-
diological status. Thus, Mattila et al. (10), Andriankaja 
et al. (15), Ying-Ouyang et al. (24), Ramirez et al. (25), 
Loesche et al. (26) and Morrison et al. (27) find a clear 
association between these parametres and cardiological 
deterioration. In the present study it is evident that PI 
as well as BOP show a sensibly worse evolution in the 
cardiac group than in the control. Even when the study 
of patients with worse cardiac evolution disappears, the 
aforementioned situation is still maintained, so that this 
would contribute in justifying Wu et al. (6) findings re-
ferring to the relationship between the poor periodontal 
hygiene indicators and the increase in plasma levels of 
inflammation markers such as C-reactive protein, high-
ly valued in coronary cardiopathy.
In the present study PD mainly increases in the cardiac 
group, and amongst these in the subgroup that will have 
a fatal evolution at the end of ten years. These results 
would be in agreement, in a good proportion, to those 
of Emingil et al. (28), that find a direct relation between 
BOP and PD with a worse coronary status (represented 
by acute myocardial infarction). In the present paper 
this worse coronary status would be represented by the 
patients who died as a consequence of coronary car-
diopathy, which likewise shows, the worst periodontal 
status. Nevertheless, it is interesting to stress that when 
this group of patients, which is going to show a worse 
evolution, disappears, PD is not going to be a periodon-
tal index with repercussion in the coronary status. It is 
possible to present the fact that the worst evolution of 
periodontal status could be related to the most severe 
cardiopathy patients. In the same way it is possible to 
highlight the Beck et al. (2) study in which deeper pock-
ets and more acute attachment losses are also associated 
with ischemic cardiopathy. Geerts et al. (29) ratify this 
same situation which has also been demonstrated in a 
woman’s only group by Buhlin et al. (30), in which a 
worse oral hygiene, an increase in PD and a worsening 
of cardiological status are associated.
It can be concluded that, in the present study, patients 
with coronary heart disease have a bad initial periodon-
tal status and presented a worse response to treatment 
than the control group, especially amongst patients who 
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die as a consequence of their cardiopathy, throughout 
the study. Nevertheless, although the present study in-
creases indices about the close relationship between a 
bad periodontal status and a bad response to the etio-
logical phase of periodontal treatment, new studies are 
needed to be able to definitely clarify the peculiarities 
of the association between both diseases.
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